References
- 1. Martineau, P., Shwed, J.A. & Denis, R. (1996). Is Octerotide a new hope for enterocutaneous and external pancreatic fistula closure? Am J Surg. 72, 386-395
- 2. Fischer, J.E. (1983). The pathophysiology of enterocutaneous fistulas. World J Surg. 7, 446-45010.1007/BF01655932
- 3. Sachdev, A., Agarwal, A. & Chowdhary, A. (1994). Management of enterocutaneous fistula. In: Chattopadhyay TK, editor. GISurgery Annual, 1, 65-84
- 4. Rubelowsky, J. & Machiedo, G.W. (1991). Reoperative versus conservative management for gastrointestinal fistulas. Surg Clin North Am. 71(1), 147-15710.1016/S0039-6109(16)45339-9
- 5. Rose, D., Yarborough, M.F., Canizaro, P.C. & Lowry, S.F. (1986). One hundred and fourteen fistulas of the gastrointestinal tract treated with parenteral nutrition. Surg Gynae Obstet. 163, 345-350
- 6. Sheldon, C.F., Gardiner, B.N. & Way, L.W. (1971). Management of gastrointestinal fistulas. Surg Gynae Obstet. 133, 385-390
- 7. Fischer, J.E. (1985). Enterocutaneous fistula. In: Norton LW, Eiseman B, editors. Surgical decision making, 2nd ed. Philadelphia, PA; WB Saunders, 146-147
- 8. Christou, N.V., Tellado-Rodriquez, J. & Chartland, L. (1989) Estimating mortality risks in preoperative patients using immunologic, nutritional and acute phase response variables. Ann Surg. 210, 69-7710.1097/00000658-198907000-00011
- 9. Ottery, F.D. (1993). Nutritional consequences of reoperative surgery for recurrent malignancy. Semin Oncol. 20, 528-537
- 10. Spiliotis, J., Briand, D. & Gouttebel, M.C. (1993). Treatment of fistulas of the gastrointestinal tract with total parenteral nutrition and octreotide in patients with carcinoma. Surg Gynecol Obstet. 176, 575-580
- 11. Reichein, S. (1983). Somatostatin. N Engl J Med. 309, 1556-1563
- 12. Chaudhry, R., Singh, B. & Subhas, P. (1997). Octreotide in gastroenterology. MJAFI. 53, 293-29410.1016/S0377-1237(17)30757-8
- 13. Paran, H., Neufeld, D., Kaplan, O., Klausner, J. & Freund, U. (1995). Octreotide for the treatment of postoperative alimentary tract fistulas. World J Surg. 19(3), 430-43410.1007/BF002991827639001
- 14. Sleth, J.C., Andraos, Y., Borie, F., Dumay, R. & Legroux P. (1994). Value of octreotide in the treatment of postoperative enterocutaneous fistulas. Ann Francaises d Anesthesie et de Reanimation. 13(5), 738-740
- 15. Kocak, S., Bumin, S., Karayalcin, K., Alacayir, I. & Aribal, D. (1994). Treatment of external biliary, pancreatic and intestinal fistulas with a somatostatin analogue. Dig Dis. 12(1), 62-6810.1159/0001714378200125
- 16. Sitges-Serra, A., Guirao, X., Pereira, J.A. & Nubiola, P. (1993) Treatment of gastrointestinal fistulas with sandostatin. Digestion. 54(Suppl 1), 38-4010.1159/0002010758359567
- 17. Hernandez-Aranda, J.C., Gappo-Chico, B., Florse-Ramirez, L.A., Avalos-Haunte, R., Magos-Vazquez, F.J. & Ramirez-Barba, E.J. (1996). Treatment of enterocutaneous fistula with or without octreotide and parenteral nutrition. Nutricion Hospitalaria. 11(4), 226-229
- 18. McIntyre, P.B., Ritchie, J.K. & Hawley, P.R. (1984). Management of enterocutaneous fistulas: a review of 132 cases. Br J Surg. 71, 292-296